Committees

Industry Committee

Charter

The Industry Committee strives to:

  • Be the global communication hub between therapeutic societies, regulatory policy makers, institutional stem cell centres and industry for the advancement of clinical investigation in cell therapy and regenerative medicine.

Projects & Objectives

The Committee

Headshot of Anthony Ting


Chair

Anthony Ting, PhD

Kiji Therapeutics
United States


2024 Members

Elsa Abranches
AstraZeneca


Sasha Aleksic
FUJIFILM

Julie Allickson
Mayo Clinic

Caroline Blumer Toti
Miltenyi Biotec

Gregg Bodnar
NMDP

Dominic Clarke 
Discovery Life Sciences 

Vincenzo DiCerbo
ESP

Miguel Forte
Kiji Therapeutics

Maya Fuerstenau-Sharp
Sartorius Stedim Biotech GmbH

Cecilia Goldenberg
Dark Horse Consulting

John Hadden
Virocell Biologics

Matthew Hewitt
Charles River Laboratories


Shanya Jiang
ESP

Scott Jones
BioBridge Global

Sven Kili 
Sven Kili Consulting Ltd

Uma Lakshmipathy 
Thermo Fisher Scientific

Bruce Levine
University of Pennsylvania School of Medicine

Fernanda Masri
Cytomos

Aby J. Mathew
BioLife Solutions

Michael May
CCRM

Bill Milligan
Steminent Biotherapeutics

Jessica Pickrell
Terumo BCT

Patrick Rivers
Aquilo Capital

Beth San Segundo
OriGen Biomedical

Alberto Santagostino
Lonza

Antonio Scatena
Gateway Analytical

David Smith
Akron Biotech

Nathan Smith
Cell Therapies Pty Ltd

Jennifer Solomon
STEMCELL Technologies

Yoshie Tsurumaki
FIRM

Martin Westberg
Cytiva

Betty Woo
Thermo Fisher Scientific